A study published in the British Journal of Pharmacology on 3 March, led by University of Queensland researchers Associate Professor Trent Woodruff and Dr John Lee, has found the drug “PMX205” extends the life of mice that have a SOD1 mutation, when administered before or during very early disease onset. More studies are now underway to determine the safety of PMX205 before it can be tested in humans. 'Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis' tttp://onlinelibrary.wiley.com/doi/10.1111/bph.13730/full
Postive results for PMX205 in mice with SOD1 mutation
Latest News
Why Gwenanne has been Walking to Defeat MND
Over two decades ago, Gwenanne’s family first took part in Walk to Defeat MND Sydney at Hyde Park in honour of her husband John, who she was caring fo...
Join our amazing supporter Don McMurray for his next MND Charity Concert
Don McMurray has been a dedicated supporter of MND NSW for over a decade, honouring the memory of his beloved wife June, who sadly passed away from MN...
Walking to Defeat MND with Zakhia
As Zakhia Aoun and her family joined the crowd at Walk to Defeat MND Sydney in 2008, for the first time they were surrounded by others who deeply unde...
Blackshaw Belconnen Bowls Day
Get keen to hit the green - the annual Blackshaw Belconnen Bowls Day is back in 2026, and this year they’ll be supporting MND NSW! Blackshaw Belconnen...